In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.
It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
All content for Tech on Drugs with Shai Shen-Orr is the property of CytoReason and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.
It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
We’re kicking off Season 3 of Tech on Drugs with Prof. Nir Hacohen — Director of the Center for Cancer Research at MGH, founding director of the Broad Institute’s Cell Circuits Program, and a distinguished member of CytoReason's Science Advisory Board.
Shai and Nir cover everything from the rise of antibodies and the promise (and pitfalls) of STING agonists, to the future of personalized cancer vaccines and a mysterious immune cell that appears only in patients with sepsis — a “cell that doesn’t exist” in healthy individuals.
This is a candid look at how deep biology, smart computation, and persistence can reshape how we treat cancer.
Tech on Drugs with Shai Shen-Orr
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.
It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
